Loews Corp Abb Vie Inc. Transaction History

Loews Corp

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$138.31 - $165.87 $1.38 Million - $1.66 Million	10,000 Added 14.29%	80,000 $12.9 Million
Q3 2022 Nov 10, 2022	SELL	$134.21 - $153.93 $1.34 Million - $1.54 Million	-10,000 Reduced 12.5%	70,000 $9.4 Million
Q1 2022 May 11, 2022	SELL	$131.98 - $163.75 $11.9 Million - $14.7 Million	-90,000 Reduced 52.94%	80,000 $13 Million
Q4 2021 Feb 11, 2022	SELL	$107.43 - $135.93 $3.22 Million - $4.08 Million	-30,000 Reduced 15.0%	170,000 $23 Million
Q3 2021 Nov 12, 2021	BUY	$106.4 - $120.78 $4.26 Million - $4.83 Million	40,000 Added 25.0%	200,000 $21.6 Million
Q2 2021 Aug 12, 2021	SELL	$105.21 - $117.21 $2.1 Million - $2.34 Million	-20,000 Reduced 11.11%	160,000 $18 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $1.53 Million - $1.69 Million	-15,000 Reduced 7.69%	180,000 $19.5 Million
Q4 2020 Feb 12, 2021	BUY	$80.49 - $108.67 $5.63 Million - $7.61 Million	70,000 Added 56.0%	195,000 $20.9 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $859,100 - $1.01 Million	-10,000 Reduced 7.41%	125,000 $10.9 Million
Q2 2020 Aug 13, 2020	SELL	$73.37 - $98.18 $1.1 Million - $1.47 Million	-15,000 Reduced 10.0%	135,000 $13.3 Million
Q1 2020 May 12, 2020	BUY	$64.5 - $97.79 $9.68 Million - $14.7 Million	150,000 New	150,000 $11.4 Million

3,795

1.28B

13M

9.82M

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $353B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

Get notified when there are updates to the investment portfolio of Loews Corp, based on Form 13F filings with the SEC.

Stay updated on Loews Corp with notifications on news.